Detalles de la búsqueda
1.
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Eur Heart J
; 43(48): 5037-5044, 2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367709
2.
Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation.
Circulation
; 140(17): 1426-1436, 2019 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634011
3.
Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle intervention.
Am Heart J
; 220: 20-28, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31765932
4.
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Catheter Cardiovasc Interv
; 94(1): 53-60, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656812
5.
Long-term use of ticagrelor in patients with prior myocardial infarction.
N Engl J Med
; 372(19): 1791-800, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773268
6.
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
Am Heart J
; 200: 83-89, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29898853
7.
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis.
Am Heart J
; 202: 54-60, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29859968
8.
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA).
Am Heart J
; 187: 170-181, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454800
9.
A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial.
Am Heart J
; 184: 121-132, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224926
10.
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Am Heart J
; 188: 73-81, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577683
11.
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Catheter Cardiovasc Interv
; 89(7): E217-E225, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650638
12.
The role of reduced heart rate volatility in predicting disposition from the emergency department.
Emerg Med J
; 34(5): 289-293, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039232
13.
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Am Heart J
; 177: 1-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297843
14.
Resistant in-stent restenosis in the drug eluting stent era.
Catheter Cardiovasc Interv
; 88(5): 777-785, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184223
15.
Low intraoperative heart rate volatility is associated with early postoperative mortality in general surgical patients: a retrospective case-control study.
J Clin Monit Comput
; 30(6): 911-918, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26477036
16.
Strategies for multivessel revascularization in patients with diabetes.
N Engl J Med
; 367(25): 2375-84, 2012 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23121323
17.
Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
Am Heart J
; 170(6): 1234-42, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678646
18.
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
Am Heart J
; 170(4): 675-682.e8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386791
19.
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
JAMA Cardiol
; 8(8): 732-741, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314801
20.
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.
Am Heart J
; 164(4): 591-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23067919